معرفی
Iman Azimi is a Senior Lecturer and Research Group Head in the Pharmacology Department at Monash Biomedicine Discovery Institute, Monash University. His academic journey includes a PhD from the University of New South Wales (2011), postdoctoral research at The University of Queensland (2011–2017), and a Lecturer role at the University of Tasmania (2018–2023). He leads research focused on brain cancer, cellular aging, calcium signaling, and drug discovery. His work is supported by grants from Cancer Council Tasmania, Brain Foundation, and others.
Education:
- PhD in Pharmacology, University of New South Wales, 2011
- Postdoctoral Fellowship, The University of Queensland, 2011–2017
Research Interests:
- Identifying therapeutic targets for brain cancers (e.g., medulloblastoma)
- Unraveling cellular aging mechanisms
- Calcium signaling in cancer and senescence
- High-throughput drug screening assay development
Publications: Recent articles focus on LIN28 proteins in medulloblastoma, T-type calcium channel inhibitors, and calcium signaling pathways. His work bridges basic science and translational applications in cancer therapy.
Awards: Includes the ASCEPT New Investigator Award (2016), Oxygen Club of California Award (2015), and multiple grants and scholarships.
Leadership & Service: Chair of Institutional Biosafety Committees, Guest Editor for Cancers and Frontiers in Pharmacology, and grant reviewer for NHMRC and international agencies.
Labs/Teams: Leads a research group at Monash focused on cancer and aging biology, with expertise in cell culture, fluorescence microscopy, and high-content imaging.
